The Europe foot and mouth disease (FMD) vaccine market is currently witnessing moderate growth. Foot and mouth disease (FMD) refers to an animal disease that affects cattle, buffaloes, pigs, sheep, and numerous other wildlife species. This disease is caused by the virus belonging to the Aphthovirus genus of the Picornaviridae family. The global disparity between virus control and eradication has created the need for effective vaccination for the disease. This vaccine is an essential tool that is used to combat FMD while optimizing vaccine-based control programs.
The Europe FMD vaccine market is primarily driven by the prevalence of FMD in the bordering countries of the European continent. The presence of two intergovernmental vaccine banks, namely the International Vaccine Bank (IVB) and the European Union Vaccine Bank (EUVB), is also propelling the growth of the market. These authorities either maintain a vaccine bank or have contracted commercial vaccine manufacturers to hold FMD vaccine and antigen on their behalf. Furthermore, as biosecurity of laboratories and vaccine production facilities is essential, the European Commission for the Control of Foot-and-Mouth Disease (EUFMD) has set detailed biosecurity aspects. Due to this, laboratories and producers in the EU have to comply with these standards to get approval under EU Directive 2003/85 to work with the FMD virus. On account of these factors, IMARC Group expects the market to continue its moderate growth during the forecast period (2021-2026).
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe foot and mouth disease (FMD) vaccine market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, animal type, vaccine type and distribution channel.
Breakup by Animal Type:
Breakup by Vaccine Type:
Breakup by Distribution Channel:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at